Abbosh, C;
Swanton, C;
(2021)
ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors.
PLoS Medicine
, 18
(10)
, Article e1003771. 10.1371/journal.pmed.1003771.
Preview |
Text
journal.pmed.1003771.pdf - Published Version Download (220kB) | Preview |
Abstract
Christopher Abbosh and Charles Swanton discuss circulating tumor DNA as a potential biomarker for neoadjuvant treatment response in solid tumors.
| Type: | Article |
|---|---|
| Title: | ctDNA: An emerging neoadjuvant biomarker in resectable solid tumors |
| Location: | United States |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1371/journal.pmed.1003771 |
| Publisher version: | https://doi.org/10.1371/journal.pmed.1003771 |
| Language: | English |
| Additional information: | © 2021 Abbosh, Swanton. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Cancer Institute > Research Department of Oncology |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10138119 |
Downloads since deposit
32Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
